AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

After seeing four of its patents for its Symbicort tossed aside, AstraZeneca has gained a key victory in defense of its blockbuster inhaler. A federal court in West Virginia upheld the company’s claim of infringement against Viatris and Kindeva Drug Delivery.